NCT07390201Completed
Effect of Sensory Integration Therapy on Gait Variability and Quality Of Life in Patients With Multiple Sclerosis
Effect of Sensory Integration Therapy on Gait Variability and Quality Of Life in Patients With Multiple Sclerosis: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 5 Aug 2026
Brief summary (registry, in English)
This study aims to evaluate the impact of sensory integration therapy on individuals with multiple sclerosis (MS) by examining its effects on gait variability and overall quality of life.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 38 (actual)
- First submitted
- 29 Jan 2026
- Start date
- 5 Feb 2026
- Primary completion date
- 20 Jul 2026
- Lead sponsor
- Cairo University
- Diseases
- Multiple sclerosis
- NCT number
- NCT07390201
What you commit to
- Study type: Interventional
- Participants enrolled: 38
- From 5 Feb 2026 to the primary completion date, 20 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Orthopedic disorders such as contracture deformities that could negatively affect gait.
- Other disorders affect gait and quality of life as (diabetes mellitus).
- Other diseases that affect Visual and vestibular problems system (such as vestibular neuritis).
Other
- Marked spasticity grade (2,3,4) for bilateral lower extremities according to modified ashworth scale.
- Pregnancy.
Who the study is looking for
- Male and female patients diagnosed with MS of relapsing-remitting at least 1 year before this study.
- The Patient's age will range from 18-45.
- A stable MS disease without any episodes of relapse within three months before the study.
- The Expanded Disability Status Scale (EDSS) scale from medical documentation (2-4.5) involve that patients have (visual, cerebellum, pyramidal brainstem and sensory) problems.
- Ability to walk six minutes' walk test (6 min walk test)
Age in the registry: 18 years to 45 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kasr Al Ainy Multiple Sclerosis Clinic Coordinator of this site? Confirm its status | Giza | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.